AIIMS Bhubaneswar is set to launch an Artificial Intelligence (AI) based diagnostic system for thyroid disorders, aiming to revolutionize early detection and personalized treatment, particularly benefiting rural and underserved populations. Addressing World Thyroid Day, AIIMS executive director Ashutosh Biswas emphasized the critical role of AI in managing hypothyroidism, a condition affecting about
1 in 10 adults in India. He noted that hypothyroidism is
three times more common in women than men, with approximately
33% of patients remaining undiagnosed.
Untreated hypothyroidism can severely impact major organs including the heart, brain, kidneys, liver, intestines, and reproductive system. In children and infants, it may cause
stunted growth, obesity, developmental delays, poor scholastic performance, constipation, and pubertal disorders.
"AI diagnosis, which is set to be introduced in AIIMS Bhubaneswar, will help in early diagnosis, track the progression of disease, and support outcome-based medication," Biswas said. This innovation is expected to improve management and outcomes for the over
500 thyroid patients treated annually at AIIMS Bhubaneswar.
The AI system aims to bridge healthcare gaps in rural areas, where access to specialized thyroid care is limited, thus enabling timely intervention and reducing complications.
"Artificial Intelligence is set to transform early diagnosis and management of thyroid disorders in the country," Biswas added, underscoring the potential of technology to enhance personalized medicine.
AIIMS Bhubaneswar will introduce AI-based diagnosis for thyroid disorders, aiming to improve early detection and personalized treatment, especially for rural patients. Hypothyroidism affects 1 in 10 adults in India, with many cases undiagnosed, and untreated conditions can severely impact multiple organs, said AIIMS executive director Ashutosh Biswas.
2